Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial 2022-04-27 00:09
The First International COVID-19 Testing Standard Released 2022-04-26 13:02
Confusing health requirements are stopping passengers from flying 2022-04-22 02:45
Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine 2022-04-21 02:36
Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan 2022-04-19 19:15
Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases 2022-04-18 22:13
WHO report highlights the role of Traditional Chinese Medicine in the treatment of COVID-19 2022-04-18 15:18
Initiating a Globally-Recognized Vaccine Passport, Indonesia's G20 HWG Meeting Series Welcome More International Visitors 2022-04-13 17:27
Receipt Of Approval From The UAE For Phase II/III Clinical Trial Of Sequential Booster Vaccination For ReCOV 2022-04-13 12:56
HIGH-TECH DROIDS UNITE AT DORSETT WANCHAI 2022-04-13 12:24
Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou 2022-04-11 16:05
Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand 2022-04-08 21:00
Tianlong COVID-19 Solution Safeguards Passengers In Jakarta International Airport In Indonesia 2022-04-08 15:04
New very-high-sensitivity rapid antigen test kits hit Australian market 2022-04-08 06:00
Everest Medicines Enters into an MOU for Partnership with China Resources Pharmaceutical Group for its mRNA Vaccine Business 2022-04-07 07:30
Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative 2022-04-06 19:37
Indonesia's G20 Health Working Group (HWG) Meeting Series Work Towards Standardization of Global Health Protocols 2022-04-05 09:00
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China 2022-04-04 08:30
Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese Patients with Chronic Hepatitis B at APASL 2022 2022-03-31 18:05
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) 2022-03-31 18:00
1 11 12 13 14 15 71